HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Leon Selected Research

Enzymes

11/2016Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Leon Research Topics

Disease

2Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2016 - 09/2015
2Infections
09/2015 - 10/2011
2Neoplasms (Cancer)
09/2015 - 10/2011
1Ataxia (Dyssynergia)
01/2022
1Hematuria
09/2021
1Fistula
09/2021
1Drug Hypersensitivity Syndrome
11/2016
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2016
1Proteinuria
09/2015
1Rheumatoid Arthritis
10/2011
1Injection Site Reaction
10/2011
1Fibrosis (Cirrhosis)
10/2010
1Atrophy
10/2010

Drug/Important Bio-Agent (IBA)

1EnzymesIBA
11/2016
1GSK2586184IBA
11/2016
1CytokinesIBA
01/2016
1CreatineIBA
09/2015
1Proteins (Proteins, Gene)FDA Link
09/2015
1AMG623 peptibodyIBA
09/2015
1B-Cell Activating FactorIBA
09/2015
1Methotrexate (Mexate)FDA LinkGeneric
10/2011
1Abatacept (Orencia)FDA Link
10/2011
1ParaffinIBA
10/2010

Therapy/Procedure

1Sphincterotomy
01/2022
1Radiotherapy
09/2021
1Aftercare (After-Treatment)
09/2021
1Vascular Surgical Procedures
09/2021